共 50 条
- [42] Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and European men WORLD JOURNAL OF UROLOGY, 2021, 39 (01) : 73 - 80
- [43] Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and European men World Journal of Urology, 2021, 39 : 73 - 80
- [45] SCREENING FOR PROSTATE CANCER: RESULTS FROM THE SWISS SECTION OF THE ERSPC (AARAU) JOURNAL OF UROLOGY, 2016, 195 (04): : E547 - E547
- [46] DAIRY INTAKE AND PROSTATE CANCER RISK: RESULTS FROM THE CALIFORNIA COLLABORATIVE PROSTATE CANCER STUDY JOURNAL OF UROLOGY, 2014, 191 (04): : E833 - E833
- [47] PROSTATE VOLUME MEASUREMENTS CAN LEAD TO LARGE ADJUSTMENTS IN THE PROBABILITY A BIOPSY FINDS PROSTATE CANCER OBTAINED FROM RISK CALCULATORS JOURNAL OF UROLOGY, 2014, 191 (04): : E711 - E711
- [49] COST-EFFECTIVENESS OF PROSTATE CANCER SCREENING BASED ON THE EUROPEAN RANDOMISED STUDY OF SCREENING FOR PROSTATE CANCER JOURNAL OF UROLOGY, 2012, 187 (04): : E491 - E491
- [50] Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Herault PROGRES EN UROLOGIE, 2009, 19 (07): : 487 - 498